Compare SLRC & IART Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SLRC | IART |
|---|---|---|
| Founded | 2007 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 803.0M | 744.3M |
| IPO Year | 2007 | 1996 |
| Metric | SLRC | IART |
|---|---|---|
| Price | $13.83 | $9.24 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 6 | 7 |
| Target Price | ★ $15.58 | $14.50 |
| AVG Volume (30 Days) | 308.8K | ★ 762.8K |
| Earning Date | 01-01-0001 | 05-25-2026 |
| Dividend Yield | ★ 11.53% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 1.70 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $1.09 | $4.45 |
| Revenue Next Year | N/A | $3.40 |
| P/E Ratio | $8.36 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $13.64 | $8.91 |
| 52 Week High | $17.26 | $23.27 |
| Indicator | SLRC | IART |
|---|---|---|
| Relative Strength Index (RSI) | 32.05 | 28.30 |
| Support Level | N/A | N/A |
| Resistance Level | $15.52 | $14.14 |
| Average True Range (ATR) | 0.38 | 0.53 |
| MACD | -0.07 | -0.15 |
| Stochastic Oscillator | 0.00 | 10.40 |
SLR Investment Corp is a closed-end externally managed, non-diversified management investment company that has elected to be treated as a business development company. It provides U.S. middle market businesses and intermediaries with bespoke debt financing solutions to fund working capital, acquisition, refinancing and growth capital requirements. The company's investment objective is to generate both current income and capital appreciation through debt and equity investments. The company invests principally in leveraged middle-market companies in the form of senior secured loans, financing leases, and to a lesser extent, unsecured loans and equity securities.
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and Tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales. The company operates in United States, Europe, Asia Pacific, and Rest of the World.